Infinity Pharmaceuticals, Inc Earning Date (INFI)

USA |NASDAQ |USD

INFI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Oct 31, 2022 Sep 2022 $-0.15 - $-0.12
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Oct 31, 2022 Sep 2022 $490.00K - $428.00K

Infinity Pharmaceuticals, Inc's next earnings date is Monday, Oct 31, 2022 for the fiscal quarter ending Sep 2022.

INFI Earnings Date & History Chart

INFI Earnings & Revenue Forecast

INFI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 5 $-0.15 $-0.16 $-0.15
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $-0.59 $-0.63 $-0.55
Dec 2023 5 $-0.68 $-0.82 $-0.51

INFI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 0 / 0 $-0.15 $-0.15 $-0.12
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.59 $-0.59 $-0.57
Dec 2023 0 / 0 $-0.68 $-0.68 $-0.60

INFI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Sep 2022 4 $490.00K $200.00K $700.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $2.25M $1.30M $2.70M
Dec 2023 5 $2.22M $800.00K $3.00M

INFI Earnings Date & Revenue History

INFI Earnings History

|
Show More
Show More

INFI Revenue History

|
Show More
Show More

Infinity Pharmaceuticals, Inc Next Earnings Date & Report

INFI Next Earnings Date & Report Preview: Sep 2022 (FQ)

INFI's next earnings date is Monday, Oct 31, 2022 for the fiscal quarter ending Sep 30, 2022.

According to analysts, the average EPS estimation for Infinity Pharmaceuticals, Inc's next quarterly earnings is $-0.15, with a low EPS estimation of $-0.16, and a high estimation of $-0.15.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.15, the last 2 month trend is $-0.15, and the 3 month trend is $-0.12.

Based on analysts, the average revenue estimation is $490.00K, with a low revenue estimation of $200.00K, and a high estimation of $700.00K.

Infinity Pharmaceuticals, Inc Previous Earnings Dates & Reports

INFI Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Infinity Pharmaceuticals, Inc's previous earnings date was Jul 27, 2022 for its fiscal quarter ended Jun 30, 2022.

INFI Previous Earnings Date & Report Recap: Dec 2021 (FY)

Infinity Pharmaceuticals, Inc's previous annual earnings date was Mar 29, 2022 for its fiscal year ended Dec 31, 2021.

INFI's earnings per share (EPS) was $-0.53, beating the consensus analysts forecast of $-0.53 by 0.00% , and higher than the previous year's EPS (Dec 2020) by -20.90%.

Revenues were $1.86M, better than the forecast of $1.73M by 7.40%, and up by 8.09% from previous year's revenue.

The company reported a net income of $-45.26M.

Infinity Pharmaceuticals, Inc reported a free cash flow of $-40.63M for its fiscal year, compared to $-35.78M a year ago.

The company ended the fiscal year with $917.00K in total debt, a decrease of -98.25% compared to the previous year.